Default company panoramic image
Bd596e00 cf15 458d bdc8 8421f540e499

ALung Technologies, Inc.

The Hemolung is a new therapy that replaces the respirator in the ICU, improves clinical outcomes and results in full payback with two weeks

  • Stage Concept Only
  • Industry Medical Devices and Equipment
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Employees 30
  • Website alung.com

Company Summary

Team

  • Default avatar
    Peter DeComo
    Chairman & CEO

  • Default avatar
    Nicholas Kuhn
    Chief Operating Officer

Advisors

  • Default avatar
    Peter Blaiser, Reed Smith
    Lawyer
    Unconfirmed
    Default avatar
    Mock, Bosco & Associates
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Blue Tree, Innovation Works, Pittsburgh Life Sciences Greenhouse and private investors||
    Unconfirmed